Research in stem cells and regenerative medicine is growing in scope, and its translation to the clinic is heralded by the recent initiation of controlled clinical trials with pluripotent derived cells. Unfortunately, stem cell ‘treatments’ are currently offered to patients outside of the controlled framework of scientifically sound research and regulated clinical trials. Both physicians and patients in reproductive medicine are often unsure about stem cells therapeutic options.
Are there effective and clinically validated stem cell-based therapies for reproductive diseases?
Read the paper>
ESHRE position statement concerning prion detection in urinary gonadotropin formulations
Share this page